Prices delayed by at least 15 minutes | Print
Puretech Health PLC (PRTC)
ORD 1POpen
144.00p
Previous close
143.00p
Trade high
144.00p
Volume
419,626
Year high
227.00p
Year low
100.40p
Dividend yield
–
Market capitalisation
£338.67 mn
P/E ratio
9.24
ISIN
GB00BY2Z0H74
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
Share price
Company profile
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, whichderives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
News
Recent trades
Date | Time | Price | Quantity | Value (£) |
---|---|---|---|---|
13/06/2025 | 04:35:20 | 141 | 29,440 | 41,510.40 |
13/06/2025 | 04:27:15 | 140.2 | 2,572 | 3,605.94 |
13/06/2025 | 04:26:30 | 140 | 209 | 292.60 |
13/06/2025 | 04:26:30 | 140 | 167 | 233.80 |
13/06/2025 | 04:26:30 | 140 | 173 | 242.20 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.